BioCentury
ARTICLE | Editor's Commentary

Biosecure litmus test: Editor’s Commentary

Lesson one from the Biosecure Act: U.S. biotech policy must focus on bolstering the domestic bioeconomy

January 2, 2025 11:41 PM UTC

The Biosecure Act streaked across the sky last year, and like a meteor, flamed out, consumed by atmospheric friction. As Congress and the Trump administration consider how biotech should factor into geopolitical rivalries, it is important to learn from the efforts over the last year to decouple the U.S. and Chinese life sciences industries.

Like most celestial phenomena, people who viewed Biosecure from below came up with a variety of explanations for its origins, causes and ultimate meaning. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article